Wayne C. Drevets
0000-0002-5097-3930
Publication & Citation Trends
Publications
0 total
Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science
Cited by 0
Semantic Scholar
Biomarker innovations in precision psychiatry diagnostics and treatment strategies.
Cited by 1
Semantic Scholar
Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study.
Cited by 0
Semantic Scholar
Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study.
Cited by 2
Semantic Scholar
Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study
Cited by 0
Semantic Scholar
Efficacy and Safety of Seltorexant in Insomnia Disorder
Cited by 5
Semantic Scholar
Pharmacological characterisation of JNJ‐78911118, a novel, centrally‐penetrant, selective GluN2A antagonist
Cited by 0
Semantic Scholar
Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study.
Cited by 4
Semantic Scholar
Research Topics
Treatment of Major Depression
(143)
Tryptophan and brain disorders
(129)
Functional Brain Connectivity Studies
(105)
Stress Responses and Cortisol
(90)
Bipolar Disorder and Treatment
(77)
Affiliations
University of Bern
United States Department of Health and Human Services
National Institutes of Health
Johnson & Johnson (United States)
Janssen (Belgium)